about
Hyperosmotic stress induces cisplatin sensitivity in ovarian cancer cells by stimulating aquaporin-5 expressionCelecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistanceQT interval prolongation and torsades de pointes with oxaliplatin.Enhancer of zeste homolog 2 promotes cisplatin resistance by reducing cellular platinum accumulation.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Oxaliplatin for the treatment of ovarian cancer.
@en
type
label
Oxaliplatin for the treatment of ovarian cancer.
@en
prefLabel
Oxaliplatin for the treatment of ovarian cancer.
@en
P2093
P2860
P1476
Oxaliplatin for the treatment of ovarian cancer
@en
P2093
Arsenio Spinillo
Barbara Gardella
Luciana Babilonti
Pier-Luigi Venturini
Stefano Bogliolo
Valentina Musacchi
P2860
P304
P356
10.1517/13543784.2015.1062874
P407
P577
2015-06-30T00:00:00Z